Genotypic Diversity of Hepatitis B and Delta Viruses in Peru: A Phylogenetic Study Using Next-Generation Sequencing.

ObjectiveTo characterize the molecular epidemiology and genomic diversity of hepatitis B virus (HBV) and hepatitis delta virus (HDV) in Peru using next-generation sequencing (NGS). Materials and MethodsA cross-sectional observational study was conducted using 209 serum/plasma samples from various regions of Peru, stored at the National Institute of Health. Detection of HBV and HDV was performed by PCR and RT-PCR, respectively. Nucleic acids were purified and quantified for library preparation and sequencing using the Illumina platform. Sequencing reads were aligned to reference genomes to determine genotypes, subgenotypes, and clinically relevant mutations. Geneious Prime was used for assembly and phylogenetic analysis, and STATA v.14.0 for statistical analysis. ResultsHBV genotype F was the most prevalent (96.1%), with subgenotype F1b being predominant, followed by genotypes H, G, and C. Mutations associated with virulence and immune escape were identified, particularly A1762T/G1764A (66.7%) and A1762T/G1764A + G1896A (45.7%). All HDV sequences corresponded to genotype 3 (HDV-3), which was detected in six regions of the country. ConclusionsThe findings confirm the predominant circulation of HBV genotype F and HDV genotype 3 in Peru, with genotypic diversity that may influence clinical outcomes, viral load, and response to treatment. Sustained molecular surveillance programs are recommended in endemic areas to guide control, treatment, and prevention strategies.